Dr. Homesley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Novant Health Orthopedic & Sports Medicine
4741 Randolph Rd, Unit 100
Charlotte, NC 28211Phone+1 704-365-6730Fax+1 704-365-6731
Summary
- Dr. H. David Homesley is an orthopedic surgeon in Charlotte, NC and is affiliated with multiple hospitals in the area, including Novant Health Charlotte Orthopaedic Hospital, Carolinas Medical Center-Mercy, and Novant Health Presbyterian Medical Center. He received his medical degree from Wake Forest School of Medicine and has been in practice 20 years. He specializes in hip & knee reconstructive surgery and is experienced in hip and knee surgery, total joint replacement, knee arthroplasty, and hip replacement arthroplasty.
Education & Training
- University of North CarolinaBA, Mathematics , Cum Laude, 1989
- Thomas Jefferson UniversityFellowship, Adult Reconstructive Orthopaedics, 2002 - 2003
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Orthopaedic Surgery, 1998 - 2002
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Orthopaedic Surgery, 1997 - 1998
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1997
- University of North CarolinaBA, Mathematics , Cum Laude, 1989 - 1993
- University of North CarolinaBA, Mathematics , Cum Laude, 1989 - 1993
Certifications & Licensure
- NC State Medical License 2003 - 2026
- VT State Medical License 2003 - 2010
- PA State Medical License 1998 - 2006
- American Board of Orthopaedic Surgery Orthopaedic Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- 268 citationsFinal overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancerKrishnansu S. Tewari, Robert A. Burger, Danielle Enserro, Barbara M. Norquist, Elizabeth M. Swisher
Journal of Clinical Oncology. 2019-06-19 - 16 citationsA phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group StudyElizabeth R. Burton, Mark F. Brady, Howard D. Homesley, Peter G. Rose, Toshiaki Nakamura
Gynecologic Oncology. 2016-01-01 - 20 citationsA phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancerHoward D. Homesley, Nathan P. Meltzer, Lucybeth Nieves, Luis Vaccarello, George S. Lowendowski
International Journal of Clinical Oncology. 2008-02-29
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: